CDC73 Gene Parathyroid Adenoma with Cystic Changes Familial Genetic Test
Test Name: CDC73 Gene Parathyroid Adenoma with Cystic Changes Familial Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CDC73 Gene Parathyroid Adenoma with Cystic Changes, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDC73 Gene Parathyroid Adenoma with Cystic Changes, familial NGS Genetic DNA Test gene CDC73
Test Details
The CDC73 gene, also known as the parafibromin gene, is associated with a condition called hyperparathyroidism-jaw tumor syndrome (HPT-JT). HPT-JT is an inherited disorder characterized by the development of parathyroid adenomas (benign tumors of the parathyroid glands) and jaw tumors.
NGS genetic testing refers to next-generation sequencing, a high-throughput method used to analyze multiple genes simultaneously. In the context of CDC73 gene testing, NGS can be used to identify mutations or variants in the CDC73 gene that may be associated with HPT-JT.
In the case of parathyroid adenoma with cystic changes, familial NGS genetic testing of the CDC73 gene can help identify any genetic alterations that may be contributing to the development of this condition within a family. By identifying specific mutations or variants in the CDC73 gene, individuals at risk for HPT-JT can be identified and appropriate medical management can be initiated, such as regular screening for parathyroid tumors and jaw tumors.
It’s important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.
| Test Name | CDC73 Gene Parathyroid adenoma with cystic changes familial Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CDC73 Gene Parathyroid adenoma with cystic changes, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDC73 Gene Parathyroid adenoma with cystic changes, familial NGS Genetic DNA Test gene CDC73 |
| Test Details |
The CDC73 gene, also known as the parafibromin gene, is associated with a condition called hyperparathyroidism-jaw tumor syndrome (HPT-JT). HPT-JT is an inherited disorder characterized by the development of parathyroid adenomas (benign tumors of the parathyroid glands) and jaw tumors. NGS genetic testing refers to next-generation sequencing, a high-throughput method used to analyze multiple genes simultaneously. In the context of CDC73 gene testing, NGS can be used to identify mutations or variants in the CDC73 gene that may be associated with HPT-JT. In the case of parathyroid adenoma with cystic changes, familial NGS genetic testing of the CDC73 gene can help identify any genetic alterations that may be contributing to the development of this condition within a family. By identifying specific mutations or variants in the CDC73 gene, individuals at risk for HPT-JT can be identified and appropriate medical management can be initiated, such as regular screening for parathyroid tumors and jaw tumors. It’s important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results. |
